ID

15365

Descripción

Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany

Link

https://clinicaltrials.gov/ct2/show/NCT02419378

Palabras clave

  1. 13/8/15 13/8/15 - Martin Dugas
  2. 28/5/16 28/5/16 -
Subido en

28 de mayo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Adverse Event Multiple Sclerosis ALAIN01 NCT02419378

Adverse Event Multiple Sclerosis ALAIN01 NCT02419378

Adverse Event
Descripción

Adverse Event

Alias
UMLS CUI-1
C0877248
AE: Sheet number
Descripción

AE: Sheet number

Tipo de datos

integer

AE: Signature date
Descripción

AE: Signature date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1519316
UMLS CUI [1,2]
C0011008
AERQG
Descripción

AERQG

AE: Number
Descripción

AE: Number

Tipo de datos

integer

Alias
UMLS CUI [1]
C2826275
AE: Term
Descripción

AE: Term

Tipo de datos

text

Alias
UMLS CUI [1]
C0877248
AE: Start date
Descripción

AE: Start date

Tipo de datos

date

Alias
UMLS CUI [1]
C2697888
AE: Serious event
Descripción

AE: Serious event

Tipo de datos

text

Alias
UMLS CUI [1]
C1519255
AE: Toxicity (CTCAE) Grade
Descripción

AE: Toxicity (CTCAE) Grade

Tipo de datos

text

Alias
UMLS CUI [1]
C2985911
AE: Relationship to study treatment
Descripción

Adverse Event Attribution to Product or Procedure

Tipo de datos

text

Alias
UMLS CUI [1]
C1510821
AE: Action taken with study treatment
Descripción

AE: Action taken with study treatment

Tipo de datos

text

Alias
UMLS CUI [1]
C2981656
AE: End date
Descripción

AE: End date

Tipo de datos

date

Alias
UMLS CUI [1]
C2697886
AE: Ongoing
Descripción

AE: Ongoing

Tipo de datos

text

Alias
UMLS CUI [1]
C2826663
AE: Outcome
Descripción

AE: Outcome

Tipo de datos

text

Alias
UMLS CUI [1]
C1705586

Similar models

Adverse Event Multiple Sclerosis ALAIN01 NCT02419378

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Adverse Event
C0877248 (UMLS CUI-1)
AE: Sheet number
Item
integer
AE: Signature date
Item
AE: Signature date
date
C1519316 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Adverse Event Number
Item
AE: Number
integer
C2826275 (UMLS CUI [1])
Adverse Event
Item
AE: Term
text
C0877248 (UMLS CUI [1])
Adverse event start date
Item
AE: Start date
date
C2697888 (UMLS CUI [1])
Item
AE: Serious event
text
C1519255 (UMLS CUI [1])
Code List
AE: Serious event
CL Item
No - AE of Special Interest (AESI) (1)
CL Item
No (0)
CL Item
Yes (2)
Item
AE: Toxicity (CTCAE) Grade
text
C2985911 (UMLS CUI [1])
Code List
AE: Toxicity (CTCAE) Grade
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
5 (5)
CL Item
0 (0)
Item
AE: Relationship to study treatment
text
C1510821 (UMLS CUI [1])
Code List
AE: Relationship to study treatment
CL Item
No reasonable possibility (0)
CL Item
Reasonable possibility (1)
Item
AE: Action taken with study treatment
text
C2981656 (UMLS CUI [1])
Code List
AE: Action taken with study treatment
CL Item
Dose not changed (0)
CL Item
Dose reduced (1)
CL Item
Dose increased (2)
CL Item
Drug withdrawn (3)
CL Item
Unknown (4)
CL Item
Not applicable (5)
Adverse event end date
Item
AE: End date
date
C2697886 (UMLS CUI [1])
Item
AE: Ongoing
text
C2826663 (UMLS CUI [1])
Code List
AE: Ongoing
CL Item
yes (1)
Item
AE: Outcome
text
C1705586 (UMLS CUI [1])
Code List
AE: Outcome
CL Item
Recovered/Resolved (0)
CL Item
Recovering/Resolving (1)
CL Item
Not recovered/Not resolved (2)
CL Item
Recovered/Resolved with sequelae (3)
CL Item
Fatal (4)
CL Item
Unknown (5)

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial